Skip to main content
Top
Published in: Clinical Rheumatology 3/2016

01-03-2016 | Brief Report

Cutaneous manifestations of patients with relapsing polychondritis: an association with extracutaneous complications

Authors: Jun Shimizu, Hiroshi Oka, Yoshihisa Yamano, Kazuo Yudoh, Noboru Suzuki

Published in: Clinical Rheumatology | Issue 3/2016

Login to get access

Abstract

The aim of this study was to determine the prognostic characteristics of patients with relapsing polychondritis (RP) accompanying cutaneous manifestations in Japan. We analyzed a cohort of 239 patients with RP in view of cutaneous and extracutaneous complications. Thirty three cases (14%) developed cutaneous manifestations and 23 cases had both cutaneous and extracutaneous manifestations. Five RP patients developed myelodysplastic syndrome (MDS) and all of the five patients had cutaneous manifestations, including Sweet’s syndrome. Only one patient died of MDS among the five patients, suggesting rather better prognosis as compared with ordinary MDS. Five RP patients developed Behcet’s disease and all the five patients had cutaneous manifestations. Death rate of the RP patients with cutaneous manifestations (15%) was slightly higher than that of whole Japanese RP patient cohort (9.2%). RP patients with cutaneous manifestations had a slightly higher death rate, than those without cutaneous manifestations. MDS of RP patients had a rather better prognostic impact in Japan. Further studies are needed to elucidate the pathophysiology of RP, which brings about development of extracutaneous manifestations, especially MDS and Behcet’s disease.
Literature
1.
go back to reference Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS (2002) Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 31:384–395CrossRefPubMed Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS (2002) Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 31:384–395CrossRefPubMed
2.
go back to reference Francès C, el Rassi R, Laporte JL, Rybojad M, Papo T, Piette JC (2001) Dermatologic manifestations of relapsing polychondritis. A study of 200 cases at a single center. Medicine (Baltimore) 80:173–179CrossRef Francès C, el Rassi R, Laporte JL, Rybojad M, Papo T, Piette JC (2001) Dermatologic manifestations of relapsing polychondritis. A study of 200 cases at a single center. Medicine (Baltimore) 80:173–179CrossRef
3.
go back to reference Dalamaga M, Karmaniolas K, Matekovits A, Migdalis I, Papadavid E (2008) Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients. J Eur Acad Dermatol Venereol 22:543–548CrossRefPubMed Dalamaga M, Karmaniolas K, Matekovits A, Migdalis I, Papadavid E (2008) Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients. J Eur Acad Dermatol Venereol 22:543–548CrossRefPubMed
4.
go back to reference Oka H, Yamano Y, Shimizu J, Yudoh K, Suzuki N (2014) A large-scale survey of patients with relapsing polychondritis in Japan. Inflamm Regen 34:149–156CrossRef Oka H, Yamano Y, Shimizu J, Yudoh K, Suzuki N (2014) A large-scale survey of patients with relapsing polychondritis in Japan. Inflamm Regen 34:149–156CrossRef
5.
go back to reference Shimizu J, Oka H, Yamano Y, Yudoh K, Suzuki N (2015) Cardiac involvement in relapsing polychondritis in Japan. Rheumatology (Oxford). [Epub ahead of print] Shimizu J, Oka H, Yamano Y, Yudoh K, Suzuki N (2015) Cardiac involvement in relapsing polychondritis in Japan. Rheumatology (Oxford). [Epub ahead of print]
6.
go back to reference Suzuki N, Shimizu J, Oka H, Yamano Y, Yudoh K (2014) Neurological involvement of relapsing polychondritis in Japan: an epidemiological study. Inflamm Regen 34:206–208CrossRef Suzuki N, Shimizu J, Oka H, Yamano Y, Yudoh K (2014) Neurological involvement of relapsing polychondritis in Japan: an epidemiological study. Inflamm Regen 34:206–208CrossRef
7.
9.
go back to reference Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 24:483–489CrossRefPubMed Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 24:483–489CrossRefPubMed
10.
go back to reference Németh-Normand F, Machet L, Vaillant L, Fontes V, Lefrancq T, Lorette G (2002) [Cutaneous vasculitis, myelodysplasia and relapsing polychondritis]. Ann Dermatol Venereol 129:1299-1302. [Article in French] Németh-Normand F, Machet L, Vaillant L, Fontes V, Lefrancq T, Lorette G (2002) [Cutaneous vasculitis, myelodysplasia and relapsing polychondritis]. Ann Dermatol Venereol 129:1299-1302. [Article in French]
Metadata
Title
Cutaneous manifestations of patients with relapsing polychondritis: an association with extracutaneous complications
Authors
Jun Shimizu
Hiroshi Oka
Yoshihisa Yamano
Kazuo Yudoh
Noboru Suzuki
Publication date
01-03-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3160-2

Other articles of this Issue 3/2016

Clinical Rheumatology 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine